INS and diabetes mellitus: Unlike insulin and proinsulin levels, which are independently associated with an increased risk of PDAC among nondiabetic patients, circulating markers, including baseline fasting blood glucose and glycated hemoglobin, are associated with the increased risk of PDAC a dose-dependent manner among patients with diabetes [42, 43].